Literature DB >> 26346971

Quality assessment of acute viral bronchiolitis clinical practice guidelines.

Carlos E Rodriguez-Martinez1,2,3, Monica P Sossa-Briceño4, Ranniery Acuña-Cordero5,6.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Recently, in an attempt to reduce variability in clinical practice and produce better results for patients, several clinical practice guidelines (CPGs) for the appropriate diagnosis and management of bronchiolitis in infants have been developed. However, the quality of available CPGs for bronchiolitis management has not yet been systematically evaluated. The aim of this study was to assess the quality of acute viral bronchiolitis CPGs.
METHOD: We performed a systematic and exhaustive search of CPGs on bronchiolitis published from 2000 to 2014. Three independent appraisers assessed the quality of the CPGs using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument. A standardized score was calculated for each of the six domains, and the CPGS were rated as recommended, recommended with modifications, or not recommended.
RESULTS: Six CPGs published between the years 2000 and 2014 were selected from a total of 111 citations. There was substantial agreement among reviewers (ICC: 0.75; 95% CI, 0.61-0.89). The domains that scored the highest were 'scope and purpose', with a mean value of 92.1% (range: 77.8-100%), and 'clarity of presentation' [83.3% (69.4-91.7%)]. Those that scored the lowest were 'applicability' [44.3% (8.3-77.1%)], and 'stakeholder involvement' [66.7% (47.2-94.4%)]. Three CPGS were evaluated as being recommended with modifications, and only two were recommended for use in clinical practice.
CONCLUSIONS: Available bronchiolitis CPGs vary in quality, and the findings of the present study are useful for identifying aspects or domains where there is room for improvement in future CPGs.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bronchiolitis; clinical practice guideline; health care quality assessment

Mesh:

Year:  2015        PMID: 26346971     DOI: 10.1111/jep.12446

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

Review 1.  The quality of guidelines on the end-of-life care: a systematic quality appraisal using AGREE II instrument.

Authors:  Alireza Irajpour; Maryam Hashemi; Fariba Taleghani
Journal:  Support Care Cancer       Date:  2019-12-13       Impact factor: 3.603

Review 2.  The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?

Authors:  Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

3.  Predictors of Inappropriate Use of Diagnostic Tests and Management of Bronchiolitis.

Authors:  Lorena Sarmiento; Gladys E Rojas-Soto; Carlos E Rodríguez-Martínez
Journal:  Biomed Res Int       Date:  2017-07-03       Impact factor: 3.411

4.  Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Gustavo Nino; Jose A Castro-Rodriguez; Geovanny F Perez; Monica P Sossa-Briceño; Jefferson A Buendia
Journal:  Pediatr Pulmonol       Date:  2020-10-20

5.  Impact of the implementation of an evidence-based guideline on diagnostic testing, management, and clinical outcomes for infants with bronchiolitis.

Authors:  Ricardo Henao-Villada; Monica P Sossa-Briceño; Carlos E Rodríguez-Martínez
Journal:  Ther Adv Respir Dis       Date:  2016-08-04       Impact factor: 4.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.